Although overall survival did not reach statistical significance, there was a trend toward improvement, with 31.0 months for the three-drug group compared to 25.8 months for the control (p = 0.054).
← all excerpts
Global research landscape of antiangiogenic therapy for colorectal cancer: a bibliometric analysis of mechanistic insights and clinical advancements.
1
0.0540
0.0540